A carregar...
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
BACKGROUND: Oxaliplatin-capecitabine (OxCap) and carboplatin-paclitaxel (CarPac) based neo-adjuvant chemoradiotherapy (nCRT) have shown promising activity in localised, resectable oesophageal cancer. PATIENTS AND METHODS: A non-blinded, randomised (1:1 via a centralised computer system), ‘pick a win...
Na minha lista:
Publicado no: | Eur J Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Elsevier Science Ltd
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341738/ https://ncbi.nlm.nih.gov/pubmed/28335886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2016.11.031 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|